Flip-flop Phenomenon
Flip-flop Phenomenon - Related Videos
01:10
Tip-of-the-Tongue Phenomenon
0 Views •
2025
The tip-of-the-tongue (TOT) phenomenon is a cognitive experience characterized by a temporary inability to retrieve specific information from memory despite having a strong feeling of knowing the information. Although individuals cannot access the target word or detail, they frequently recall related elements, such as its initial letter, syllable count, or context. This partial retrieval often causes frustration, as one might recognize a familiar face or know that a name starts with a specific...
05:25
Patterning of Embryonic Stem Cells Using the Bio Flip Chip
0 Views •
Cited by 2 •
2007
We demonstrate a simple method for placing cells at desired locations on a substrate. This method patterns cells by flipping a silicone chip containing microwells filled with cells onto the substrate. This method provides a new way to modulate diffusible and juxtacrine signaling between cells.
08:21
Laser-induced Forward Transfer for Flip-chip Packaging of Single Dies
0 Views •
Cited by 5 •
2015
We demonstrate the use of the Laser-induced Forward Transfer (LIFT) technique for flip-chip assembly of optoelectronic components. This approach provides a simple, cost-effective, low-temperature, fast and flexible solution for fine-pitch bumping and bonding on chip-scale for achieving high-density circuits for optoelectronic applications.
12:55
Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
0 Views •
Cited by 32 •
2015
The term anastasis refers to the phenomenon in which dying cells reverse a cell suicide process at a late stage, repair themselves, and ultimately survive. Here we demonstrate protocols for detecting and tracking cells that undergo anastasis.
09:18
Photobleaching Assays (FRAP & FLIP) to Measure Chromatin Protein Dynamics in Living Embryonic Stem Cells
0 Views •
Cited by 26 •
2011
We describe photobleaching methods including Fluorescence Recovery After Photobleaching (FRAP) and Fluorescence Loss In Photobleaching (FLIP) to monitor chromatin protein dynamics in embryonic stem (ES) cells. Chromatin protein dynamics, which is considered to be one of the means to study chromatin plasticity, is enhanced in pluripotent cells.
FAQs
The terminal slope can be misleading because the observed late decline is governed by the slower process. In flip-flop kinetics, absorption limits how quickly drug enters the circulation, so concentrations continue declining according to absorption rather than elimination. Interpreting that slope as clearance can therefore overstate how long the body itself retains the drug.
Formulation design is central: extended-release and depot products can delay drug absorption after extravascular dosing. If this delay makes the absorption rate constant lower than the elimination rate constant, the concentration-time profile develops a terminal phase controlled by absorption. The resulting profile reflects formulation performance as well as drug disposition.
An apparently prolonged half-life does not necessarily indicate slow drug elimination. When flip-flop kinetics are present, the terminal phase can make the calculated half-life appear longer because it reflects slow absorption. The same misinterpretation may distort clearance estimates, so half-life and clearance should be interpreted in relation to the absorption process and dosage form.
Investigators can identify the phenomenon by examining concentration-time data from extravascular studies and asking which rate process controls the terminal phase. Evidence that the terminal decline reflects absorption, with an absorption rate constant below the elimination rate constant, supports flip-flop kinetics. This check prevents a terminal slope from being assigned automatically to clearance.
Recognition matters when selecting dosing intervals. A prolonged apparent terminal phase may influence expectations about how long concentrations persist, even though it reflects slow entry from the formulation rather than unusually slow elimination. Accounting for this distinction helps clinical drug development teams interpret exposure profiles and avoid basing schedules on a misleading half-life.
Formulation comparisons can use flip-flop kinetics to evaluate how release or depot characteristics shape the concentration-time profile. A product that absorbs slowly may show a longer apparent terminal phase without a corresponding change in elimination. Recognizing this pattern helps investigators separate formulation behavior from drug disposition when assessing performance in clinical development.